Mr. Speaker, I have the honour to present, in both official languages, the third report of the Standing Committee on Public Accounts relating to audit observations contained in the April 1999 report of the Auditor General of Canada entitled “National Defence and Health Canada: Non-compliance with conditions and inadequate monitoring with respect to the pre-licensing use of an anti-malarial drug”.
Pursuant to Standing Order 109 of the House of Commons, the committee requests the government to table a comprehensive response to this report.